| 國立臺灣大學 |
2009 |
IL-6 經由Smad恢復TGF-beta對樹狀細胞成熟的抑制
|
陳墨繁; Chen, Mo-Fan |
| 國立臺灣大學 |
2015 |
IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: a cohort study
|
Kao, Jung-Ta; Feng, Chun-Lung; Yu, Cheng-Ju; Tsai, Shu-Mei; Hsu, Ping-Ning; Chen, Yao-Li; Wu, Yi-Ying; 許秉寧 |
| 臺大學術典藏 |
2021-02-02T02:47:59Z |
IL-6, through p-STAT3 rather than p-STAT1, activates hepatocarcinogenesis and affects survival of hepatocellular carcinoma patients: A cohort study
|
Kao J.-T.; Feng C.-L.; Yu C.-J.; Tsai S.-M.; PING-NING HSU; Chen Y.-L.; Wu Y.-Y. |
| 國立臺灣大學 |
2007 |
Il-6-Encoding Tumor Antigen Generates Potent Cancer Immunotherapy through Antigen Processing and Anti-Apoptotic Pathways
|
謝長堯; 陳祈安; 黃家彥; 張明正; 李建南; 蘇怡寧; 鄭文芳; HSIEH, CHANG-YAO; CHEN, CHI-AN; HUANG, CHIA-YEN; CHANG, MING-CHENG; LEE, CHIEN-NAN; SU, YI-NING; CHENG, WEN-FANG |
| 臺大學術典藏 |
2007 |
IL-6-encoding tumor antigen generates potent cancer immunotherapy through antigen processing and anti-apoptotic pathways
|
CHIEN-NAN LEE; WEN-FANG CHENG; CHI-AN CHEN; Hsieh, C.-Y. and Chen, C.-A. and Huang, C.-Y. and Chang, M.-C. and Lee, C.-N. and Su, Y.-N. and Cheng, W.-F. |
| 臺大學術典藏 |
2020-01-22T07:50:45Z |
IL-6-encoding tumor antigen generates potent cancer immunotherapy through antigen processing and anti-apoptotic pathways
|
Cheng W.-F.; Su Y.-N.; Lee C.-N.; Chang M.-C.; Huang C.-Y.; CHI-AN CHEN; Hsieh C.-Y.; Hsieh C.-Y.;Chi-An Chen;Huang C.-Y.;Chang M.-C.;Lee C.-N.;Su Y.-N.;Cheng W.-F. |
| 臺大學術典藏 |
2020-02-06T05:22:23Z |
IL-6-encoding tumor antigen generates potent cancer immunotherapy through antigen processing and anti-apoptotic pathways
|
WEN-FANG CHENG;Su Y.-N.;Lee C.-N.;Chang M.-C.;Huang C.-Y.;Chen C.-A.;Hsieh C.-Y.; Hsieh C.-Y.; Chen C.-A.; Huang C.-Y.; Chang M.-C.; Lee C.-N.; Su Y.-N.; WEN-FANG CHENG; Hsieh C.-Y.; Chen C.-A.; Huang C.-Y.; Chang M.-C.; Lee C.-N.; Su Y.-N.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-12T04:06:10Z |
IL-6-encoding tumor antigen generates potent cancer immunotherapy through antigen processing and anti-apoptotic pathways
|
Cheng W.-F.;Su Y.-N;CHIEN-NAN LEE;Chang M.-C;Huang C.-Y;Chen C.-A;Hsieh C.-Y; Hsieh C.-Y; Chen C.-A; Huang C.-Y; Chang M.-C; CHIEN-NAN LEE; Su Y.-N; Cheng W.-F. |
| 臺大學術典藏 |
2020-02-14T02:50:06Z |
IL-6-encoding tumor antigen generates potent cancer immunotherapy through antigen processing and anti-apoptotic pathways
|
Hsieh C.-Y.;Chen C.-A.;Huang C.-Y.;Chang M.-C.;Lee C.-N.;Su Y.-N.;Wen-Fang Cheng; Hsieh C.-Y.; Chen C.-A.; Huang C.-Y.; Chang M.-C.; Lee C.-N.; Su Y.-N.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-11-27T08:14:25Z |
IL-6-encoding tumor antigen generates potent cancer immunotherapy through antigen processing and anti-apoptotic pathways
|
Chang-Yao Hsieh;Chen C.-A.;Huang C.-Y.;Chang M.-C.;Lee C.-N.;Su Y.-N.;Cheng W.-F.; CHANG-YAO HSIEH; Chen C.-A.; Huang C.-Y.; Chang M.-C.; Lee C.-N.; Su Y.-N.; Cheng W.-F. |
| 臺大學術典藏 |
2021-02-04T06:05:02Z |
IL-6-encoding tumor antigen generates potent cancer immunotherapy through antigen processing and anti-apoptotic pathways
|
Hsieh C.-Y.;Chen C.-A.;Huang C.-Y.;Chang M.-C.;Chien-Nan Lee;Su Y.-N.;Cheng W.-F.; Hsieh C.-Y.; Chen C.-A.; Huang C.-Y.; Chang M.-C.; CHIEN-NAN LEE; Su Y.-N.; Cheng W.-F. |
| 國立臺灣大學 |
2007-10 |
IL-6-encoding tumor antigen generates potent cancer immunotherapy through antigen processing and anti-apoptotic pathways.
|
Hsieh, CY; Chen, CA; Huang, CY; Chang, MC; Lee, CN; Su, YN; Cheng, WF |
| 國家衛生研究院 |
2010-06 |
IL-6-transfected tumor cells modulate the status of CD8+ and CD4+ T cells to control tumor growth
|
Hsieh, CL;Liu, SJ;Shen, CR;Chen, MY;Hsu, SC;Tsai, JP;Li, YS;Yang, CJ;Chong, P;Chen, HW |
| 中國醫藥大學 |
2010-06 |
IL-6-transfected tumor cells modulate the status of CD8+ and CD4+ T cells to control tumor growth
|
謝嘉齡(Chia-Ling Hsieh); 劉士仕(Shih-Jen Liu); 沈家瑞(Chia-Rui Shen); 陳玫瑜(Mei-Yu Chen); 許素菁(Shu-Ching Hsu); 蔡之平(Jy-Ping Tsai); 李宜軒(Yi-Shiuan Li); 楊靜仁(Ching-Jen Yang); 莊再成(Pele Chong); 陳信偉(Hsin-Wei Chen)* |
| 臺北醫學大學 |
2010 |
IL-6刺激人類肺部纖維母細胞結締組織生長因子表現之分子機轉探討
|
蔡睿益 |
| 中國醫藥大學 |
2018-12-04 |
IL-6參與lapatinib引發三陰性乳癌轉移之探討
|
蕭宇君;Yu-Chun Hsiao |
| 國立臺灣大學 |
2016 |
IL-6反式訊息傳遞途徑在放射線導致之肺纖維化中所扮演的角色
|
吳晉睿; Wu, Chin-Jui |
| 元培科技大學 |
2017-11-13 |
IL-6受體抗體在k-ras突變的結腸直腸癌細胞上抑制體內腫瘤生長和血管
|
劉葦君;徐治平;鍾元強 |
| 元培科技大學 |
2020 |
IL-6和VEGF-A信號傳導抑制劑聯合療法對大腸癌細胞的抑制效果
|
葉家銨 |
| 國立成功大學 |
2009-06-26 |
IL-6和惡性胸水肺腺癌臨床及免疫調控相關性
|
李妍蒨; Lee, Yen-Chien |
| 國立成功大學 |
2011-01-24 |
IL-6的分泌與肺癌病人存活時間的相關性與抑制IL-6分泌的方法
|
葉裕民; Yeh, Yu-Min |
| 國立臺灣大學 |
2008-07-31 |
IL-6調控人類基底細胞癌之趨化激素及其受體表現與其對腫瘤生物特性之影響(3/3)
|
紀秀華 |
| 國立臺灣大學 |
2015 |
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer
|
Liu, Yi-Nan; Chang, Tzu-Hua; Tsai, Meng-Feng; Wu, Shang-Gin; Tsai, Tzu-Hsiu; Chen, Hsuan-Yu; Yu, Sung-Liang; Yang, James Chih-Hsin; Shih, Jin-Yuan; 楊志新; 俞松良; 吳尚俊; 蔡子修; 施金元 |
| 臺大學術典藏 |
2018-09-10T15:17:53Z |
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer
|
Liu, Y.-N. and Chang, T.-H. and Tsai, M.-F. and Wu, S.-G. and Tsai, T.-H. and Chen, H.-Y. and Yu, S.-L. and Yang, J.C.-H. and Shih, J.-Y.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-05-26T09:26:56Z |
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer
|
Shih J.-Y.;Chih-Hsin Yang;Yu S.-L;Chen H.-Y;Tsai T.-H;Wu S.-G;Tsai M.-F;Chang T.-H;Liu Y.-N; Liu Y.-N; Chang T.-H; Tsai M.-F; Wu S.-G; Tsai T.-H; Chen H.-Y; Yu S.-L; CHIH-HSIN YANG; Shih J.-Y. |
| 臺大學術典藏 |
2020-07-21T06:25:17Z |
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer
|
Shih J.-Y.; Liu Y.-N.;Chang T.-H.;Tsai M.-F.;Wu S.-G.;Tzu-Hsiu Tsai;Chen H.-Y.;Yu S.-L.;Yang J.C.-H.;Shih J.-Y.; Liu Y.-N.; Chang T.-H.; Tsai M.-F.; Wu S.-G.; TZU-HSIU TSAI; Chen H.-Y.; Yu S.-L.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-08-12T08:25:24Z |
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer
|
Chen H.-Y.; Yu S.-L.; Yang J.C.-H.; Shih J.-Y.; Tsai T.-H.; SHANG-GIN WU; Tsai M.-F.; Chang T.-H.; Liu Y.-N. |
| 臺大學術典藏 |
2020-08-13T06:33:44Z |
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer
|
JIN-YUAN SHIH; Yang J.C.-H.; Yu S.-L.; Liu Y.-N.; Chang T.-H.; Tsai M.-F.; Wu S.-G.; Tsai T.-H.; Chen H.-Y. |
| 大葉大學 |
2015-04 |
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer.
|
Liu, Yi-Nan;Chang, Tzu-Hua;Tsai, Meng-Feng;Wu, Shang-Gin;Tsai, Tzu-Hsiu;Chen, Hsuan-Yu;Yu, Sung-Liang;Yang, James Chih-Hsin;Shih, Jin-Yuan |
| 中國醫藥大學 |
2011-09 |
IL-8 increases integrin expression and cell motility in human chondrosarcoma cells
|
李俊億(Chun-Yi Lee); 黃俊寅(Chun-Yin Huang); 陳孟意(Meng-Yi Chen); 林清淵(Ching-Yuang Lin); 許弘昌(Horng-Chaung Hsu); 湯智昕(Tang Chih-Hsin)* |
| 國家衛生研究院 |
2016-06 |
IL-8 induces miR-424-5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma
|
Peng, HY;Jiang, SS;Hsiao, JR;Hsiao, M;Hsu, YM;Wu, GH;Chang, WM;Chang, JY;Jin, CSL;Shiah, SG |
| 國立成功大學 |
2016-06 |
IL-8 induces miR-424-5p expression and modulates SOCS2/STAT5 signaling pathway in oral squamous cell carcinoma
|
Peng, Hsuan-Yu;Jiang, Shih-Sheng;Hsiao, Jenn-Ren;Hsiao, Michael;Hsu, Yuan-Ming;Wu, Guan-Hsun;Chang, Wei-Min;Chang, Jang-Yang;Jin, Shiow-Lian Catherine;Shiah, Shine-Gwo |
| 嘉南藥理大學 |
2016-09 |
IL-8 promotes HNSCC progression on CXCR1/2-meidated NOD1/RIP2 signaling pathway
|
Chan, Leong-Perng; Wang, Ling-Feng; Chiang, Feng-Yu; Lee, Ka-Wo; Kuo, Po-Lin; Liang, Chia-Hua |
| 國立成功大學 |
2015-09-03 |
IL-8在胰臟癌惡病質中所扮演的角色
|
陳浩雲; Chen, Hao-Yun |
| 國家衛生研究院 |
2015-06 |
IL-9 induces IL-8 production via STIM1 activation and ERK phosphorylation in epidermal keratinocytes: A plausible mechanism of IL-9R in atopic dermatitis
|
Hong, CH;Chang, KL;Wang, HJ;Yu, HS;Lee, CH |
| 國家衛生研究院 |
2015-05 |
IL-9/IL-9R of epidermal keratinocytes in atopic dermatitis: IL-9 induces IL-8 production through STIM1 activation and ERK phosphorylation
|
Lee, C;Hong, C;Hsin-Su, Y |
| 國立臺灣大學 |
1998 |
IL-IRA對肺部抗原專－性免疫反應的影響
|
林榮華 |
| 國立成功大學 |
2016 |
IL1 beta 在血流引起之肺高壓的角色
|
阮俊能;羅傳堯;許志新 |
| 國立臺灣大學 |
2009 |
Il10 and Il10 Receptor Gene Variation and Outcomes after Unrelated and Related Hematopoietic Cell Transplantation
|
曾麗慧; 林敏哲; 陳培哲; TSENG, LI-HUI; LIN, MING-TSEH; CHEN, PEI-JER |
| 臺大學術典藏 |
2018-09-10T07:24:55Z |
IL10 and IL10 Receptor Gene Variation and Outcomes After Unrelated and Related Hematopoietic Cell Transplantation
|
Tseng, L.-H.;Storer, B.;Petersdorf, E.;Lin, M.-T.;Chien, J.W.;Grogan, B.M.;Malkki, M.;Chen, P.-J.;Zhao, L.P.;Martin, P.J.;Hansen, J.A.; LI-HUI TSENG |
| 臺大學術典藏 |
2021-07-03T03:34:51Z |
IL10 and IL10 Receptor Gene Variation and Outcomes After Unrelated and Related Hematopoietic Cell Transplantation
|
Tseng L.-H.; Storer B.; Petersdorf E.; Lin M.-T.; Chien J.W.; Grogan B.M.; Malkki M.; PEI-JER CHEN; Zhao L.P.; Martin P.J.; Hansen J.A. |
| 臺大學術典藏 |
2022-03-10T07:58:48Z |
IL10 and IL10 Receptor Gene Variation and Outcomes After Unrelated and Related Hematopoietic Cell Transplantation
|
LI-HUI TSENG; Storer B.; Petersdorf E.; Lin M.-T.; Chien J.W.; Grogan B.M.; Malkki M.; Chen P.-J.; Zhao L.P.; Martin P.J.; Hansen J.A. |
| 中國醫藥大學 |
2011-07-31 |
IL10基因型表現型之關聯及其與中台灣地區鼻咽癌癌化關聯性之研究
|
鄒永恩(Yung-An Tsou); 蔡銘修(Ming-Hsui Tsai) |
| 國立成功大學 |
2015-10 |
IL17a and IL21 combined with surgical status predict the outcome of ovarian cancer patients
|
Chen, Yu-Li; Chou, Cheng-Yang; Chang, Ming-Cheng; Lin, Han-Wei; Huang, Ching-Ting; Hsieh, Shu-Feng; Chen, Chi-An; Cheng, Wen-Fang |
| 臺大學術典藏 |
2018-09-10T15:28:31Z |
IL17a and IL21 combined with surgical status predict the outcome of ovarian cancer patients
|
Chen, Yu-Li;Chou, Cheng-Yang;Chang, Ming-Cheng;Lin, Han-Wei;Huang, Ching-Ting;Hsieh, Shu-Feng;Chen, Chi-An;Cheng, Wen-Fang; Chen, Yu-Li;Chou, Cheng-Yang;Chang, Ming-Cheng;Lin, Han-Wei;Huang, Ching-Ting;Hsieh, Shu-Feng;Chen, Chi-An;Cheng, Wen-Fang; Chen, Y.-L. and Chou, C.-Y. and Chang, M.-C. and Lin, H.-W. and Huang, C.-T. and Hsieh, S.-F. and Chen, C.-A. and Cheng, W.-F.; 鄭文芳;陳祈安;陳玉怜; 鄭文芳;陳祈安;陳玉怜; CHI-AN CHEN; Chen, Yu-Li; Chen, Yu-Li; Chou, Cheng-Yang; Chou, Cheng-Yang; Hsiao, Chen-Hsi; Chang, Ming-Cheng; Lin, Han-Wei; Lin, Han-Wei; Huang, Ching-Ting; Hsieh, Shu-Feng; Chen, Chi-An; Chen, Chi-An; Cheng, Wen-Fang; Cheng, Wen-Fang; ????? |
| 臺大學術典藏 |
2020-01-22T07:50:29Z |
IL17a and IL21 combined with surgical status predict the outcome of ovarian cancer patients
|
Huang C.-T.; Hsieh S.-F.; CHI-AN CHEN; Cheng W.-F.; Chen Y.-L.; Chou C.-Y.; Chang M.-C.; Lin H.-W. |
| 臺大學術典藏 |
2020-02-06T05:21:58Z |
IL17a and IL21 combined with surgical status predict the outcome of ovarian cancer patients
|
WEN-FANG CHENG;Chen C.-A.;Hsieh S.-F.;Huang C.-T.;Lin H.-W.;Chang M.-C.;Chou C.-Y.;Chen Y.-L.; Chen Y.-L.; Chou C.-Y.; Chang M.-C.; Lin H.-W.; Huang C.-T.; Hsieh S.-F.; Chen C.-A.; WEN-FANG CHENG; Chen Y.-L.; Chou C.-Y.; Chang M.-C.; Lin H.-W.; Huang C.-T.; Hsieh S.-F.; Chen C.-A.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-14T02:49:47Z |
IL17a and IL21 combined with surgical status predict the outcome of ovarian cancer patients
|
Chen Y.-L.;Chou C.-Y.;Chang M.-C.;Lin H.-W.;Huang C.-T.;Hsieh S.-F.;Chen C.-A.;Wen-Fang Cheng; Chen Y.-L.; Chou C.-Y.; Chang M.-C.; Lin H.-W.; Huang C.-T.; Hsieh S.-F.; Chen C.-A.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-05-24T06:00:19Z |
IL17a and IL21 combined with surgical status predict the outcome of ovarian cancer patients
|
YU-LI CHEN; Chou C.-Y.; Chang M.-C.; Lin H.-W.; Huang C.-T.; Hsieh S.-F.; Chen C.-A.; Cheng W.-F. |
| 臺大學術典藏 |
2021-02-04T02:39:55Z |
IL17a and IL21 combined with surgical status predict the outcome of ovarian cancer patients
|
Yu-Li Chen;Chou C.-Y.;Chang M.-C.;Lin H.-W.;Huang C.-T.;Hsieh S.-F.;Chen C.-A.;Cheng W.-F.; YU-LI CHEN; Chou C.-Y.; Chang M.-C.; Lin H.-W.; Huang C.-T.; Hsieh S.-F.; Chen C.-A.; Cheng W.-F. |
